13 Hrs
المصدر:
Chicago Tribune
Grail's cancer test under FDA review
A blood test intended to detect multiple cancers in asymptomatic individuals is undergoing its first significant regulatory review by U.S. government advisers.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading